AOA 2024: Clinical evaluation of a novel lipid-containing eye drop versus an existing lubricating eye drop

News
Video

Jade Coats, OD, details 2 poster presentations on the benefits found in a novel lipid-containing eye drop during AOA's 2024 Optometry's Meeting.

Jade Coats, OD, gave 2 posters presentations at this year's AOA Optometry's Meeting in Nashville, Tennessee, running from June 19-22. Both presentations were on clinical findings of a novel lipid-containing eye drop.

Video transcript

Editor's note: This transcript has been lightly edited for clarity.

Jade Coats, OD:

Hi, my name is Jade Coats and I practice at McDonald Eye Associates in northwest Arkansas. Today I was able to present 2 posters at AOA and both of them involving lipid-based nano-emulsion drop technology. And what we found, the reason why we really studied this and really the reason why we dove deeper is because there might be a level of concern that practitioners have when we add a lipid to an artificial tear, that it could blur vision. Well, in this case, what we studied was a non-inferiority study versus a non-lipid containing eyedrops. And not only did we find that it improved comfort compared to baseline, but it also had beneficial effects on vision at the endpoint. So what we have found with this study is we tend to divide dry eye patients into aqueous deficient or evaporative dry eye, but in realistic times, they're really a combination of both. And so what we found in this study is that lipid nano[-emulsion] eyedrops may be beneficial for all. They may be beneficial for both categories of dry eye and ocular surface disease.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
© 2025 MJH Life Sciences

All rights reserved.